Atlas Trials

Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma

Clinical trial NCT07469735 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07469735
Sponsor
Huashan Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
GliomaDiffuse GliomaRecurrent Gliomas
Start date
2026-04-01
Primary completion
2027-06-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.